GLP2-T
60mg
⚠️ Not for human consumption. Research purposes only.
Description
GLP2-T is a dual GIP/GLP-1 receptor agonist investigated in preclinical and clinical-stage metabolic research. Published studies characterize its binding affinity at both incretin receptor subtypes, with data on downstream cAMP signaling, insulin secretion kinetics, and gastric motility modulation in animal models. This compound is supplied as a lyophilized research material for in vitro and in vivo laboratory use only.
Key Areas of Study
- Dual incretin receptor binding studies
- cAMP signaling pathway analysis
- insulin secretion kinetics research
- gastric motility modulation modeling
Mechanisms Being Evaluated
Engages both the GIP and GLP-1 receptor subtypes, activating adenylyl cyclase–cAMP cascades in pancreatic beta-cell models. Preclinical data indicate modulation of gastric emptying rate and hypothalamic appetite-signaling circuits via vagal afferent pathways.
Commonly Researched Uses
Incretin receptor pharmacology research, beta-cell signaling studies, gastric motility modeling, metabolic pathway investigation in preclinical models